SARS‐CoV‐2 is a newly discovered beta coronavirus at the end of 2019, which is highly
pathogenic and poses a serious threat to human health. In this paper, 1875 SARS‐CoV‐2 …

This study assessed adverse events following immunizations (AEFIs) reported on COVID-19
vaccines in VigiAccess and determined the reporting trends across all continents of the …

Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new
species of β-coronavirus genus named severe acute respiratory syndrome coronavirus 2 …

Disease X is caused by pathogen X, an unknown infectious agent that can potentially trigger
an epidemic or pandemic. Pathogen X might be any pathogen, including bacteria, viruses …

Purpose The purpose of this paper spans twofold. Firstly, to investigate Human Resource
Management practices (HRMP) adopted by organisations during the pandemic. Secondly, to …

Many countries in the world are experiencing a recent surge in COVID‐19 cases. This is
mainly attributed to the emergence of new SARS‐CoV‐2 variants. Genome sequencing is …

COVID-19 pneumonia is heterogeneous disease with variable effect on lung parenchyma,
airways and vasculature leading to long term effects on lung functions. Although Lung is the …

With the emergence and wide spread of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) variants of concern (VOCs), such as the Delta variant (B. 1.617. 2 lineage …

Background In order to impart immunity against SARS COV 2 in the community, the oil rich
countries of the Gulf Cooperation Council (GCC) provided citizens and expatriates with free …

From June 2021 until August 2021, Indonesia experienced an unprecedented surge in the
number of daily new confirmed coronavirus disease 2019 (COVID-19) cases. We, as authors …